Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs

著者： Annenberg Center for Health Sciences
無料で聴く

  • サマリー

  • Patients with long-chain fatty oxidation disorders (LC-FAODs) have historically been treated with diet modification and even-carbon medium-chain triglyceride (MCT) supplementation. In this 45-minute, case-based, modular activity, Sandra van Calcar, PhD, RD, LD, and Jerry Vockley, MD, PhD, address key topics, including disease presentation, historical treatment, emerging treatment with triheptanoin, and nutritional planning specific to patients with LC-FAODs.
    Annenberg Center for Health Sciences
    続きを読む 一部表示

あらすじ・解説

Patients with long-chain fatty oxidation disorders (LC-FAODs) have historically been treated with diet modification and even-carbon medium-chain triglyceride (MCT) supplementation. In this 45-minute, case-based, modular activity, Sandra van Calcar, PhD, RD, LD, and Jerry Vockley, MD, PhD, address key topics, including disease presentation, historical treatment, emerging treatment with triheptanoin, and nutritional planning specific to patients with LC-FAODs.
Annenberg Center for Health Sciences
衛生・健康的な生活 身体的病い・疾患
続きを読む 一部表示
エピソード
  • Clinical Case Vignettes

    Clinical Case Vignettes
    2024/11/14
    • Initiating triheptanoin
    • Dosing modification to improve tolerability
    続きを読む 一部表示
    10 分
  • Optimizing Triheptanoin Therapy

    Optimizing Triheptanoin Therapy
    2024/11/14
    • Clinical safety and efficacy
    • Initiation and titration
    • Administration considerations
    • Individualizing treatment
    続きを読む 一部表示
    19 分
  • Historical Treatment; Introduction of Triheptanoin

    Historical Treatment; Introduction of Triheptanoin
    2024/11/14
    • Dietary modification
    • MCT supplementation
    • Triheptanoin mechanism of action
    続きを読む 一部表示
    6 分

Bridging Gaps, Optimizing Treatment in Patients With LC-FAODsに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。